-
Claim Trends
Pharmacy Focus: Rethymic® — A Therapy for Pediatric Patients with Congenital Athymia
-
Claim Trends
Pharmacy Focus: Roctavian™ — Long-Awaited Gene Therapy for Hemophilia A
-
Claim Trends
Pharmacy Focus: Elevidys — A New Gene Therapy for Duchenne Muscular Dystrophy (DMD)
-
Claim Trends
Pharmacy Focus: Adstiladrin® – A New Gene Therapy for a Specific Type of Bladder Cancer
-
Claim Trends
Pharmacy Focus: Pipeline Therapies 2023
-
Claim Trends
Pharmacy Focus: Hemgenix® – A New Gene Therapy for Hemophilia B
-
Claim Trends
Pharmacy Focus: LentiGlobin – A New Gene Therapy for Sickle Cell Disease
-
Claim Trends
Pharmacy Focus: Skysona® – A New Gene Therapy for Cerebral Adrenoleukodystrophy (cALD)
-
Claim Trends
Pharmacy Focus: Zynteglo - New Gene Therapy for Beta Thalassemia
-
Claim Trends
Pharmacy Focus: Enzyme Replacement Therapy
-
Claim Trends
Pharmacy Focus: Treatment of AADC Deficiency
-
Claim Trends
Pharmacy Focus: The Evolution of Cancer Treatment
-
Company and Product Information
What Is Leveraged Trend?
-
Cost Containment
Pharmacy Focus: Dissecting Gene Therapies
-
Industry Knowledge and Trends
Catastrophic Risk Protection in a Post-Pandemic World
-
Claim Trends
Pharmacy Focus: Infertility Programs and High-Cost Newborns
-
Cost Containment Tips and Trends
Pharmacy Focus: Duchenne Muscular Dystrophy Treatment
-
Claim Trends
Pharmacy Focus: Hereditary Angioedema Treatment
-
Cost Containment
Pharmacy Focus: CAR T-Cell Therapy 2020 Update
-
Company and Product Information
HMConnects™ Video
-
Company and Product Information
Stop Loss Business Resilience Amid a Pandemic
-
Cost Drivers
Pharmacy Focus: Spinal Muscular Atrophy (SMA) Treatment
-
Company and Product Information
HM Insurance Group’s Managed Care Reinsurance History
View Sales Materials
-
Cost Containment
High-Cost Pharmaceuticals and Therapies – New Approvals and the Pipeline to Watch through 2021
View Sales Materials
-
Company and Product Information
Managed Care Reinsurance Case Study: High-Dollar Claim Bill Review
View Sales Materials
-
Cost Containment Tips and Trends
Pharmacy Focus: Current and Upcoming Hemophilia Treatment
-
Industry Knowledge and Trends
Risk vs Reward -- Two Actuaries Break Down Level Funding
-
Cost Containment
Claim Picture: Coronavirus Disease (COVID-19)
-
Company and Product Information
Using Data to Empower Smart Stop Loss Decisions
-
Claim Trends
HM Sparks Article: Level Funding
-
Company and Product Information
Managed Care Reinsurance Cost Containment Vendors
View Sales Materials
-
Cost Containment
Case Study: Stem Cell Transplant Swift Payment and Cost Reduction
View Sales Materials
-
Cost Containment
Delivering Proactive Pharmaceutical Cost Management Opportunities: Zolgensma®
View Sales Materials
-
Cost Drivers
Gene Therapy: Tiny Target, Colossal Costs
-
Cost Containment Tips and Trends
Pharmacy Focus: Spinal Muscular Atrophy Treatment
-
Company and Product Information
Managed Care Reinsurance eServices Quick Hints Guide
View Sales Materials
-
Cost Containment
Smart Practices for Addressing High Claims Costs
-
Claim Trends
Pharmacy Focus: 2018 Opioid Updates
-
Company and Product Information
RBS Re eServices Quick Hints Guide
-
Company and Product Information
High Performance Stop Loss
-
Cost Containment
Pharmacy Focus: 2018 Cancer Therapy Update
-
Industry Knowledge and Trends
Protecting Self-Funded Plans with Stop Loss Backed by Smart Practices
-
Industry Knowledge and Trends
Protecting Self-Funded Plans with Stop Loss Backed by Smart Practices
-
Commission Direct Deposit
-
Sea Island NSC Invitation Booklet 2018
-
Claim Trends
HM Sparks Article: Cancer Drug Cost Growth Trend
-
Network Questionnaire Data Request Template
-
Claim Trends
HM Sparks Article: Preterm Births
-
Cost Drivers
HM Sparks Article: Inflammatory Condition Drugs
-
Cost Drivers
HM Sparks Article: Specialty Pharmaceuticals
-
Cost Containment
HM Sparks Article: Referenced-Based Pricing
-
Industry Knowledge and Trends
HM Sparks Article: Carriers Versus MGUs
-
The Strength of the HM Contract
-
CSI Policy HMIG
-
HIPAA Highmark Casualty
-
HIPAA Highmark Casualty Spanish
-
HIPAA HM Insurance Group Spanish
-
HIPAA HM Insurance Group
-
RBS Re Notification Form
-
RBS Re Claim Form
-
RBS Re Premium Invoice Transmittal
-
Cost Containment Tips and Trends
HM Trend Watch: The Rising Costs of Specialty Pharmaceuticals
View Sales Materials
-
Cost Containment
HM Sparks Article: Narrow Networks
-
Company and Product Information
HM Insurance Group: Delivering Quality and Confidence
-
Industry Knowledge and Trends
The Value of Stop Loss Insurance
-
Company and Product Information
HM Insurance Group By the Numbers
-
Cost Containment
HM Sparks Article: Proactive Cost Containment
-
Cost Containment
HM Sparks Article: Price Transparency
-
Cost Drivers
HM Sparks Article: Congenital Birth Defects and Claim Costs
-
Cost Containment
HM Sparks Article: Rising Claim Costs and the Importance of Stop Loss
-
Monthly Aggregate Report Highmark Casualty Insurance Company
-
Monthly Aggregate Report HM Life Insurance Company of New York
-
Monthly Aggregate Report HM Life Insurance Company
-
Company and Product Information
HM Insurance Group Company Financial and Product Overview
View Sales Materials
-
Cost Containment Tips and Trends
As Claim Costs Rise the Importance of Stop Loss Grows
-
Stop Loss Insurance eBill Benefits
-
Cost Containment Tips and Trends
How Do Smart Stop Loss Carriers Work to Manage Claim Costs for Their Clients?
-
HM Corporate and Stop Loss Overview
What Is Essential to a Strong Stop Loss Insurance Contract?
-
Industry Knowledge and Trends
How Do I Select the Right Carrier?
-
Industry Knowledge and Trends
How Does Stop Loss Protect?
-
Industry Knowledge and Trends
Who Should Self-Fund
-
Industry Knowledge and Trends
What is Self-Funding?
-
Company and Product Information
Stop Loss Financial Protection for Self-Funded Groups
View Sales Materials
-
Stop Loss a Solid Contract for Better Protection